Britannia Life Sciences Inc. reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported net income was CAD 3.42 million compared to CAD 0.623009 million a year ago. Basic earnings per share from continuing operations was CAD 0.03.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | -33.33% | -33.33% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 59.29L | |
+17.10% | 843.95Cr | |
+7.54% | 777.52Cr | |
+14.30% | 677.4Cr | |
-3.38% | 381.36Cr | |
-7.34% | 371.09Cr | |
+1.78% | 140.16Cr | |
-28.44% | 108.66Cr | |
+18.84% | 102.67Cr | |
-10.84% | 90Cr |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022